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Receptor-interacting protein kinase (RIPK)-1 is
involved in RIPK3-dependent and -independent
signaling pathways leading to cell death and/or
inflammation. Genetic ablation of ripk1 causes post-
natal lethality, which was not prevented by deletion
of ripk3, caspase-8, or fadd. However, animals that
lack RIPK1, RIPK3, and either caspase-8 or FADD
survived weaning and matured normally. RIPK1
functions in vitro to limit caspase-8-dependent,
TNFR-induced apoptosis, and animals lacking
RIPK1, RIPK3, and TNFR1 survive to adulthood.
The role of RIPK3 in promoting lethality in ripk1/
mice suggests that RIPK3 activation is inhibited by
RIPK1 postbirth. Whereas TNFR-induced RIPK3-
dependent necroptosis requires RIPK1, cells lacking
RIPK1 were sensitized to necroptosis triggered by
poly I:C or interferons. Disruption of TLR (TRIF) or
type I interferon (IFNAR) signaling delayed lethality
in ripk1/tnfr1/ mice. These results clarify the
complex roles for RIPK1 in postnatal life and provide
insights into the regulation of FADD-caspase-8 and
RIPK3-MLKL signaling by RIPK1.
INTRODUCTION
RIPK1 is a kinase with several roles in signaling by TNFR1 (Biton
and Ashkenazi, 2011; Cusson et al., 2002; Kelliher et al., 1998;
Vandenabeele et al., 2010; Zhang et al., 2000), Toll-like receptors
(TLRs) (Festjens et al., 2007; Kaiser et al., 2013; Meylan et al.,
2004), interferons (Meylan et al., 2004; Thapa et al., 2013), the
RIG-I-MAVS pathway (Rajput et al., 2011), and production of
IL1a in SHP1-deficient animals (Lukens et al., 2013). Upon acti-
vation, it associates with RIPK3 to form a b-amyloid (Li et al.,
2012), promoting necroptosis and inflammatory cytokine pro-
duction, dependent on the pseudokinase, MLKL (Kang et al.,
2013; Murphy et al., 2013). In its kinase-active form, it also
recruits the adaptor molecule, FADD, which in turn activatescaspase-8 to promote apoptosis induced by TLR signaling or
DNA damage (Tenev et al., 2011;Wang et al., 2008). These activ-
ities of RIPK1 are effectively blocked by necrostatins, including
necrostatin-1 (Nec1) (Degterev et al., 2008), which act to inhibit
the kinase function. Independent of its kinase activity, RIPK1
appears to participate in NF-kB activation through the recruit-
ment of NEMO (Micheau et al., 2001; Wang et al., 2008; Zhang
et al., 2000), although its requirement for NF-kB activation in
response to TNFR1 ligation is controversial (Wong et al., 2010).
Nevertheless, the activation of NF-kB induces the expression
of c-FLIPL (FLIP), a caspase-like molecule that forms a hetero-
dimer with caspase-8 on FADD and blocks FADD-caspase-8-
mediated apoptosis (Micheau et al., 2001; Wang et al., 2008).
The FADD-caspase-8-FLIP complex functions to inhibit RIPK3
activation, blocking necroptosis. Indeed, early embryonic
lethality of fadd/ or casp8/ animals is rescued by ablation
of ripk3 (Dillon et al., 2012; Kaiser et al., 2011; Oberst et al.,
2011), and a similar lethality of FLIP-deficient (cflar/) mice is
rescued by ablation of both fadd and ripk3 (Dillon et al., 2012).
Together, these findings provided what appeared to be a
complete picture of the interactions of FADD-caspase-8-FLIP
and the RIPK1-RIPK3-MLKL complexes in the control of cell
death (Green et al., 2011).
A fundamental paradox emerged, however, when the func-
tion of RIPK1 was interrogated by genetic approaches.
Although the embryonic lethality of fadd/ mice was rescued
by ablation of ripk1, these animals died around postnatal day
1 (Zhang et al., 2011), as had been observed for ripk1/
mice (Kelliher et al., 1998). But if RIPK1 were required for the
activation of RIPK3, as discussed above, then fadd/ripk1/
animals should have survived to adulthood, as do fadd/
ripk3/ mice (Dillon et al., 2012). The postnatal lethality of
ripk1/ animals was therefore most easily explained as being
due to the loss of another function of RIPK1 that is a requisite
for postnatal survival. For example, RIPK1 has been suggested
to regulate the induction of NF-kB by recruitment of NEMO
(Zhang et al., 2000). Perturbation of the NF-kB pathway by
ablation of RIPK1 might then trigger the noncanonical NF-
kB2, as is also observed upon deletion of other elements of
the canonical NF-kB pathway (Varfolomeev et al., 2007; Vince
et al., 2007; Gentle et al., 2011).Cell 157, 1189–1202, May 22, 2014 ª2014 Elsevier Inc. 1189
Figure 1. Lethality of ripk1/ Mice Is
Rescued by Concomitant Ablation of ripk3
and caspase-8 or fadd
(A) Compilation of pup survival of the given geno-
types from various crosses. See Figures S1B,
S1D, and S1F for survival data from the individual
crosses. The numbers in brackets refer to the
number of individual pups of each genotype.
(B) Expected and observed frequency of geno-
types in offspring at weaning from crosses of
ripk1+/ripk3/casp8/ and ripk1+/ripk3/
casp8+/mice (p = 0.8465 for comparison of ripk1
status among ripk3/casp8/ genotypes).
(C) Expected and observed frequency of geno-
types in offspring at weaning from crosses of
ripk1+/ripk3/fadd/ and ripk1+/ripk3/
fadd+/ mice (p = 0.9592 for comparison of ripk1
status among ripk3/fadd/ genotypes).
(D) Weight versus age of male ripk1/ripk3/
casp8/ or control littermates (p = 0.8539).
(E) 5-week-old ripk1/ripk3/casp8/ mouse
(arrow) and littermate control.
(F) 5-week-old ripk1/ripk3/fadd/ mouse
(arrow) and littermate control.
(G) As in (D) but for ripk1/ripk3/fadd/males
or control littermates (p = 0.2787).
See also Figure S1.An alternative to this explanation, however, is that RIPK1 func-
tions to inhibit both FADD-caspase-8-mediated apoptosis and
RIPK3-mediated necroptosis, both triggered by signals gener-
ated around the time of birth. This idea stands in striking contrast
to the widespread notion that RIPK1, in its kinase-active form,
initiates both FADD-caspase-8 mediated apoptosis (Feoktistova
et al., 2011; Tenev et al., 2011) and RIPK3 activation to cause
necroptosis (Cho et al., 2009; Holler et al., 2000). However,
both caspase-8 (Wang et al., 2008) and RIPK3 (Kaiser et al.,
2013; Moujalled et al., 2013; Upton et al., 2012) can be activated
in the absence of RIPK1 in some settings, resulting in different
forms of cell death. If RIPK1 can block cell death in these set-
tings, then this might explain why its ablation leads to lethality.
Here, we test these ideas by several approaches.
RESULTS
Perinatal Lethality of ripk1/ Mice Is Dependent on
Caspase-8 and RIPK3
To test the possibility that perinatal lethality in the ripk1/
mouse is due to overactivation of NF-kB2, we generated mice
lacking both RIPK1 and the NF-kB2-activator, NIK. Like RIPK1,
NIK is regulated by c-IAP1 and c-IAP2 (Varfolomeev et al.,
2007; Vince et al., 2007). Further, TRAF2 or TRAF3 ablation
cause perinatal lethality that is prevented on a background1190 Cell 157, 1189–1202, May 22, 2014 ª2014 Elsevier Inc.lacking NIK (Vallabhapurapu et al.,
2008). Nevertheless, we found that
ripk1/nik/ mice did not display any
improved survival versus animals lacking
RIPK1 alone, and no animals survived to
weaning (Figure S1A available online).Therefore, the perinatal lethality caused by loss of RIPK1 is not
due to enhanced activity of NIK.
We therefore tested the notion that RIPK1 functions to inhibit
two modes of cell death, such that ablation of this protein results
in lethality. Although we found that postnatal lethality of ripk1/
mice was, at best, only marginally affected by ablation of ripk3
(Figures 1A, S1B, and S1C) and unaffected by ablation of
casp8 (Figures 1A, S1D, and S1E), animals lacking ripk1, ripk3,
and casp8 survived into adulthood (Figure 1A, S1F, and S1G)
and were weaned at Mendelian frequencies (Figure 1B). Simi-
larly, whereas fadd/ripk1/ mice do not survive the first
days of postnatal life (Zhang et al., 2011), mice lacking ripk1,
ripk3, and fadd were weaned at expected frequencies (Fig-
ure 1C). Ripk1/ripk3/casp8/ and ripk1/ripk3/
fadd/ mice gained weight over time and appeared similar to
their littermates for several months (Figures 1D–1G). Formally,
then, the ripk1 gene inhibits perinatal lethality dependent on
ripk3 and either casp8 or fadd.
Ripk3/casp8/ mice eventually display acute lymphoproli-
ferative syndrome (ALPS), normally associated with defects in
CD95 signaling (Kaiser et al., 2011; Oberst et al., 2011). Similarly,
ripk1/ripk3/casp8/ animals matured normally (Figures 1D
and 1E) and displayed ALPS after several months (Figure 2A),
with expansion of the CD3+B220+ lymphocyte subset associ-
ated with ALPS (Bide`re et al., 2006) (Figures 2B and 2C). ALPS
Figure 2. Aging ripk1/ripk3/casp8/ Animals Develop an ALPS-like Phenotype, yet They Have a Normal Immune System when Young
(A) Lymphoid organs at 16 weeks.
(B) FACS analysis of cells stained with anti-CD3 and anti-B220 taken from 16-week-old animals of the indicated genotypes.
(C and D) Percentage of CD3+B220+ cells among peripheral blood mononuclear cells in mice of the indicated genotypes and ages. Data are representative of at
least three animals per group. Error bars represent SD.
(E) Percentage of CD62LhiCD44 cells in CD4+ and CD8+ T cell populations from spleens of 4-week-old mice of the indicated genotypes. Data are representative
of at least three animals per group. Error bars represent SD.
(F) CFSE dilution of 3-week-old anti-CD3 and anti-CD28-activated splenic naive CD4+ and CD8+ T cells. Blue line corresponds to ripk1+/+ripk3/casp8/ cells,
and red line corresponds to ripk1/ripk3/casp8/ cells.was also observed in ripk3/fadd/ mice (Dillon et al., 2012),
and the expansion of the aberrant lymphocyte subset was simi-
larly seen in ripk1/ripk3/fadd/ mice (Figure 2D). Naive
T cells from young ripk1/ripk3/casp8/ animals were pre-sent in normal proportions (Figure 2E) and were activated
similarly to WT T cells in response to CD3, CD28 ligation (Fig-
ure 2F). Therefore, RIPK1 is not required for in vitro T cell activa-
tion or for the expansion of lymphocytes in ALPS.Cell 157, 1189–1202, May 22, 2014 ª2014 Elsevier Inc. 1191
Figure 3. Loss of RIPK1 Potentiates TNF-
Mediated Apoptosis, which Is Independent
of RIPK3
(A) Schematic of the role of RIPK1 in cell death in
response to TNF. In WT cells (left), ligation of
TNFR1 by TNF leads to activation of RIPK1. Acti-
vated RIPK1 upregulates FLIP, which favors the
formation of caspase-8-FLIP heterodimers. These
heterodimers suppress apoptosis mediated
through FADD-caspase-8 as well as necrosis
mediated through the RIPK1-RIPK3-MLKL axis.
Inhibition of the heterodimer by zVAD increases
RIPK3-necrotic cell death, whereas RIPK1 inhibi-
tion by Nec1 prevents it. Upon TNFR1 ligation in
the absence of RIPK1 (right), RIPK3 cannot be
engaged and cells do not die by necrosis. FLIP,
however, is not upregulated, allowing the forma-
tion of caspase-8 homodimers and subsequent
apoptosis.
(B) Cell death assessed by propidium iodide and
annexin V (dark gray bars) or cleaved caspase-3
staining (light-gray bars) of primary MEF of the
specified genotypes treated in the presence or
absence of TNF (10 ng/ml), zVAD (50 mM), CHX
(25 ng/ml), and/or Nec1 (30 mM) as indicated. Data
are representative of three independent experi-
ments. Error bars represent SD.
(C) Basal or (D) induced (10 ng/ml TNF for 6 hr)
expression of cFLIPL determined via qPCR using
two separate sets of primers (set #1 and set #2,
see Experimental Procedures for sequences).
Error bars represent SD.
(E and F) Expression of cFLIPL determined via
qPCR using primer set #1 from the (E) spleen or (F)
lung of P1 pups of the indicated genotypes. Error
bars represent SD. For qPCR data, relative
expression (arbitrary units) is expressed as a ratio
of cFLIPL versus control signal (L32), whereas fold
increase represents ratio of relative expression
from end of treatment with TNF (T6h) versus start
of experiment (T0h).
See also Figure S2.TNFR1-Induced Caspase-8 Activation Contributes to
Perinatal Lethality in ripk1/ripk3/ Mice
The role of caspase-8 in the postnatal lethality of ripk1/
ripk3/ animals suggests that RIPK1 functions to inhibit
caspase-8-mediated apoptosis in some settings (Figure 3A).
Indeed, RIPK1-deficient primary MEF were strikingly sensitized
to apoptosis induced by treatment with TNF plus low-dose
cycloheximide (CHX), showing cleavage of caspase-3, and this
cell death was blocked by the caspase inhibitor N-benzyloxycar-
bonyl-Val-Ala-Asp (O-Me) fluoromethyl ketone (zVAD) (Figures
3B, S2A, and S2B). This is consistent with earlier observations
that ripk1/-primary MEF are sensitized for cell death induced
by TNF plus CHX (Kelliher et al., 1998). Similarly, ripk1/
ripk3/ MEF, but not ripk1/ripk3/casp8/ MEF, were1192 Cell 157, 1189–1202, May 22, 2014 ª2014 Elsevier Inc.sensitized to TNF plus CHX-induced
apoptosis (Figures 3B, S2A, and S2B).
Thus, the loss of RIPK1 sensitized cells
to TNF-induced, caspase-8-dependentapoptosis. This is likely due to defects in expression of FLIP,
as primary ripk1/ MEF showed reduced basal levels of FLIP
mRNA as compared to WT MEF (Figure 3C) and did not upregu-
late FLIP mRNA levels upon exposure to TNF (Figure 3D). In
contrast, we observed no alterations in expression of three other
regulators of TNFR1 signaling: c-IAP1, c-IAP2, and X-IAP (Fig-
ure S2C). Similarly, we observed that endogenous, constitutive
expression of FLIP in spleen and lung was reduced in animals
lacking RIPK1 (Figures 3E and 3F). FLIP levels are well known
to regulate sensitivity to TNF-induced apoptosis (Budd et al.,
2006; Micheau et al., 2001; Wittkopf et al., 2013). FLIP is also
required (in the form of the FADD-FLIP-caspase-8 complex) for
inhibition of necroptosis induced by TNF (Oberst et al., 2011),
and thus, animals with low FLIP expression due to loss of
RIPK1 may be sensitized to necroptosis. However, RIPK1 is
required for TNF-induced necroptosis (Vandenabeele et al.,
2010), as we observed in response to TNF plus zVAD, which
triggered caspase-3-independent cell death in WT, but not in
primary ripk1/ MEF (Figure 3B).
We therefore investigated the role of TNF in the postnatal
lethality of ripk1/ripk3/ mice. Although ablation of tnfr1 in
ripk1/ mice delays but does not rescue postnatal lethality
(Cusson et al., 2002) (Figure S3A), we observed that ripk1/
ripk3/tnfr1/ mice survived weaning into adulthood at Men-
delian frequencies (Figures 4A–4C). Although these mice initially
matured normally and did not manifest ALPS (Figure S3B), we
noted mortality with time (Figure 4A), and this was associated
with blood bacteremia (Figure S3C), decreased blood lympho-
cyte, and increased blood neutrophil levels (Figure S3D), consis-
tent with sepsis. Even shortly after weaning (P25), intestinal
morphology was disrupted with associated apoptosis (Fig-
ure S3E), suggesting that a breakdown in barrier function even-
tually contributes to mortality in animals lacking tnfr1, ripk1, and
ripk3. Nevertheless, ablation of tnfr1 clearly rescues perinatal
lethality in ripk1/ripk3/ mice.
Our results show that ablation of casp8, fadd, or tnfr1 can pre-
vent perinatal lethality in ripk1/ripk3/ mice. Based on our
in vitro studies, it is likely that one RIPK1 function is to sustain
postnatal development by inhibiting TNFR1-induced, FADD-
caspase-8-dependent apoptosis in one or more critical tissues.
Indeed, we observed cell death accompanied by cleaved cas-
pase-3 staining in the intestines, spleens, and lungs of ripk1/
ripk3/ animals (Figures 4D–4F). Consistent with our in vitro
studies, we observed that the expression of FLIP was decreased
in ripk1/ripk3/ spleen and lung, as compared toWT (Figures
3E and 3F) (expression in intestine was too low to detect; data
not shown). Previous studies (Kelliher et al., 1998) suggested
that ripk1/ mice show defects in not only these tissues, but
also in thymus and brown fat. Although we did not observe
extensive thymocyte cell death in either ripk1/ or ripk1/
ripk3/ mice (data not shown), both brown and white fat in
ripk1/ ripk3/ mice showed a marked depletion of lipid
stores, without overt apoptosis (Figures S3F and S3G), suggest-
ing that these animals were energetically compromised.
TNFR1-InducedRIPK1Activity CausesE10.5 Lethality in
caspase-8-Deficient Mice
We observed that ablation of RIPK1 rescues the embryonic
lethality of casp8/ mice (Figures 1A and S1D), consistent
with the similar rescue of embryonic lethality in fadd/ mice
on the ripk1/ background (Zhang et al., 2011). Thus, although
deletion of caspase-8 or fadd alone did not rescue the perinatal
lethality seen in ripk1/mice, the embryonic lethality in fadd- or
caspase-8-deficient animals is dependent on RIPK1. Because
TNF-induced necroptosis in the absence of FADD-caspase-8-
FLIP activity is dependent on RIPK1 (Vandenabeele et al., 2010
and Figure 3B), we asked whether TNFR1 signaling might
contribute to the E10.5 embryonic lethality in caspase-8- or
fadd-deficient mice. Although casp8/tnfr1/ mice did not
survive to birth, we observed that these animals progressed
well beyond E10.5 in development (Figures 5A–5C), as the
fadd/tnfr1/ embryos also did (Figure 5H). The E10.5 lethalityin casp8/ mice is associated with a failure to vascularize the
yolk sac (Sakamaki et al., 2002); however, casp8/tnfr1/
mice showed normal vascular development (Figure 5D). Simi-
larly, animals lacking FLIP (cflar/) (Yeh et al., 2000) or FLIP
and RIPK3 (Dillon et al., 2012) die at E10.5, again with a failure
to vascularize the yolk sac (Dillon et al., 2012). As seen in
casp8/tnfr1/ mice, cflar/tnfr1/ and cflar/tnfr1/
ripk3/ mice survived this embryonic stage as well (Figures
5E–5G and 5I). These data show that the E10.5 lethality of
mice lacking FADD, FLIP, or caspase-8 is triggered by TNFR1
and, in the cases of fadd- or caspase-8-null embryos, is depen-
dent on RIPK1.
TRIF and Interferons Engage RIPK3-Dependent
Lethality in ripk1/tnfr1/ Mice
Although ablation of fadd, caspase-8, or tnfr1 rescues perinatal
lethality in ripk1/ripk3/ mice, it does not do so in ripk1/
mice (Cusson et al., 2002; Zhang et al., 2011) (Figures 1, 4A,
S1D, and S3A). This suggests that a second signal, besides
TNFR1, must engage RIPK3 to promote lethality in the absence
of RIPK1 (Figure 6A). In addition, in vitro evidence suggests that
the signal that engages RIPK3 cannot be via TNFR1. Primary WT
MEF underwent caspase-independent necrosis in response to
TNF plus zVAD, which was inhibited by the RIPK1 inhibitor,
Nec1 (Figure 3B), as expected (Oberst et al., 2011; Vandena-
beele et al., 2010), and was absent in treated ripk1/MEF (Fig-
ure 3B). Therefore, TNF-mediated necroptosis requires RIPK1,
as previously described (Vandenabeele et al., 2010), as seen
with other death ligands (Holler et al., 2000). However, our
genetic results strongly indicated not only that lethal RIPK3
signaling can proceed independently of RIPK1, but that RIPK1
functions to inhibit this signaling in a critical postnatal setting
(Figure 6A). We therefore sought a second signal for RIPK3 acti-
vation that is exacerbated by ablation of RIPK1.
The DNA-dependent activator of interferon regulatory factors,
DAI, can directly engage RIPK3 to promote necroptosis inde-
pendently of RIPK1, but the presence or absence of RIPK1
does not affect this interaction (Upton et al., 2012). In contrast,
poly I:C signaling via TLR3 and TRIF may promote necroptosis
that is exacerbated by silencing RIPK1 (Kaiser et al., 2013). We
therefore generated ripk1/tnfr1/trif/ mice. Although few
animals survived until weaning, we observed a significant delay
in mortality as compared to ripk1/tnfr1/ mice (p = 0.008)
or ripk1/trif/ mice (p < 0.0001) (Figure 6B). Therefore,
signaling via TRIF may serve as one relevant ‘‘signal 2’’ to trigger
RIPK3-dependent lethality in the absence of RIPK1 (Figure 6A).
We then asked whether TRIF could engage RIPK3 in the
absence of RIPK1. We stably expressed Fv2-TRIF-HA (a modifi-
cation of an FKBP domain allowing dimerization upon addition of
the rapalog, AP-20187 [AP-1] [Amara et al., 1997]) in 3T3-SA
cells. Addition of dimerizer induced robust cell death only upon
addition of zVAD or upon silencing of RIPK1 (without a require-
ment for zVAD) (Figure 6C). Pull-down of TRIF optimally coimmu-
noprecipitated RIPK1, RIPK3, and MLKL in control cells only in
the presence of AP-1 and zVAD (Figure 6D). In contrast, in cells
with silenced RIPK1, AP1 treatment was sufficient to pull down
RIPK3 and MLKL, without a requirement for zVAD (Figure 6D).
Thus, TRIF can bind RIPK3 independently of RIPK1, and in theCell 157, 1189–1202, May 22, 2014 ª2014 Elsevier Inc. 1193
Figure 4. Ablation of tnfr1 Rescues the Perinatal Lethality of ripk1/ripk3/ Mice
(A) Survival of pups from intercrosses of ripk1+/ripk3/tnfr1+/ animals. ripk1/ripk3/tnfr1/ survival was compared to ripk1/ripk3/tnfr1+/+ (p < 0.0001) and
ripk1/ripk3/tnfr1+/ (p<0.0001).Ripk1/ripk3/tnfr1/ survivalwasalsocomparedto ripk1+/+ripk3/tnfr1all (p<0.0001)and ripk1+/ripk3/tnfr1all (p<0.0001).
(B) Expected and observed frequency of genotypes in offspring at weaning from intercrosses of ripk1+/ripk3/tnfr1+/ mice (p < 0.0001 versus expected
Mendelian ratios).
(C) 6-week-old ripk1/ripk3/tnfr1/ (arrow) and littermate control.
(D–F) Hematoxylin and eosin-stained (H & E), cleaved caspase-3 immunostaining and TUNEL staining of sections of (D) duodenum, (E) spleen, and (F) lung from
ripk1/ripk3/ or control animals. Images are representative of three independent experiments.
See also Figure S3.
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Figure 5. TNFR1-Induced RIPK1 Activity
Causes E10.5 Lethality in Caspase-8-Defi-
cient Mice
(A) Expected and observed frequency of geno-
types in embryos between E14 and E17 from in-
tercrosses of casp8+/tnfr1/ mice (p = 0.5658
versus expected Mendelian ratios).
(B) E16.5 casp8/tnfr1/ embryo and casp8+/+
tnfr1/ littermate control.
(C) Hematoxylin and eosin-stained sections of
whole fixed E16.5 casp8/tnfr1/ and casp8+/+
tnfr1/ embryos.
(D) Vascularization of yolk sac from E16.5
casp8/tnfr1/ embryo.
(E) Expected and observed frequency of geno-
types in embryos between E14 and E17 from in-
tercrosses of cflar+/tnfr1/ripk3/ mice (p =
0.2068 versus expected Mendelian ratios).
(F) E16.5 cflar/tnfr1/ripk3/ embryo and
cflar+/+tnfr1/ripk3/ littermate control.
(G) Hematoxylin and eosin-stained sections of
whole fixed E16.5 cflar/tnfr1/ripk3/ and
cflar+/+tnfr1/ripk3/ embryos.
(H) Expected and observed frequency of geno-
types in embryos between E14 and E17 from in-
tercrosses of fadd+/tnfr1/ mice (p = 0.9858
versus expected Mendelian ratios).
(I) Expected and observed frequency of genotypes
in embryos between E14 and E17 from in-
tercrosses of cflar+/tnfr1/ mice (p = 0.1897
versus expected Mendelian ratios).presence of RIPK1, caspase-8 activity (Kaiser et al., 2013) antag-
onizes RIPK3 function in necroptosis.
Consistent with these observations, we saw that poly I:C treat-
ment of WT immortalized MEF-induced cell death only upon
addition of zVAD or upon silencing of RIPK1, without a require-
ment for zVAD (Figures S4A and S4B). Silencing of caspase-8
similarly sensitized primary MEF to poly I:C, as described (Kaiser
et al., 2013) (Figure S4C). Nec1 inhibited cell death induced by
poly I:C plus zVAD, but only in the presence of RIPK1 (Figures
S4A and S4B). We then employed immortalized mlkl/ MEF,
stably expressing an inducible FLAG-tagged MLKL to further
interrogate these effects (Figures 6E–6H). Addition of zVAD
plus poly I:C induced cell death in cells expressing C-terminal,
but not N-terminal, tagged MLKL, and this death was inhibited
by Nec1 (Figures 6E and 6F). Both tagged forms of MLKL copre-
cipitated RIPK1 and RIPK3 under these necroptotic conditions,
and this association was blocked by Nec1 in both cases (Fig-Cell 157, 1189–12ure 6G). Upon silencing RIPK1, the cell
death response to poly I:C, even in the
absence of zVAD, was enhanced, and
Nec1 did not prevent this cell death (Fig-
ures 6E and 6F). RIPK3 coprecipitated
with MLKL in RIPK1-silenced cells only
in response to poly I:C, with no effect of
Nec1 (Figure 6G). In contrast, in immortal-
ized WT MEF expressing N-terminal
tagged MLKL (as well as endogenous
MLKL), treatment with TNF plus zVADinduced the association of MLKL, RIPK3, and RIPK1, which
was lost upon treatment with Nec-1 or silencing of RIPK1 (Fig-
ure S4D). Nec1 addition only partially reduced the amount of
RIPK3 coimmunoprecipitated with RIPK1 but prevented its
association with MLKL (Figure 6H). The resulting cell death
was MLKL dependent, as poly I:C-induced cell death in
RIPK1-silenced cells was not observed in mlkl/ cells (Figures
S4E and S4F). Therefore, in contrast to TNF-induced necro-
ptosis, RIPK1 is dispensable for poly I:C-induced necroptosis
and can inhibit it either through recruitment of caspase activity
(blocked by zVAD) or in its Nec1-inhibited form, independently
of caspase activity (Figure 6A).
Although deletion of TRIF significantly delayed lethality in
ripk1/tnfr1/ mice, most of these animals did not survive to
weaning (Figure 6B). TRIF is therefore not the only relevant
‘‘signal 2’’ that can engage RIPK3-MLKL interaction, antago-
nized by RIPK1 (Figure 6A). Interferons (IFN) reportedly induce02, May 22, 2014 ª2014 Elsevier Inc. 1195
(legend on next page)
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necroptosis (Thapa et al., 2013) and thus might represent such a
signal. We therefore generated ripk1/tnfr1/ifnar/ mice
lacking the type I IFN receptor. These animals survived signifi-
cantly longer than did ripk1/ tnfr1/ mice (p < 0.0001) or
ripk1/ifnar/ mice (p < 0.0001) (Figure 7A). As ifnar/ mice
possess receptors for type II IFN, we compared the effects
of IFNb and IFNg on primary MEF in vitro. We observed that
primary MEF lacking RIPK1 were sensitized to both type I and
type II IFN-induced cell death that required RIPK3, indepen-
dently of caspase-8 (Figures 7B–7D, S5A, and S5B). In primary
WT MEF, IFNs induced cell death only in the presence of
zVAD, and this was inhibited by Nec1 (Figures 7C and 7D). In
contrast, IFN-induced cell death in RIPK1-deficient cells was
unaffected by either zVAD or Nec1 (Figures 7C and 7D), although
the IFN response, as detected by expression of STAT1 or PKR,
was equivalent in WT and ripk1/cells (Figures S5C and S5D).
Cell death induced by IFN was not observed in primary MEF
lacking MLKL (Figures 7E, S5E, and S5F) and was blocked by
silencing or pharmacologic inhibition of PKR, as described
(Thapa et al., 2013) (Figures S5G–S5J).
Interferon treatment of primary WT or ripk1/MEF promoted
similar upregulation of MLKL, but not RIPK3 (Figures S6A–S6C),
as described (Thapa et al., 2013), and this upregulation was not
observed upon treatment with TNF or poly I:C (Figures S6D–
S6F). We noted that MLKL levels were consistently lower in
ripk1/ versus WT in three matched sets of primary MEF
(Figure S6A and data not shown). It is possible that this reflects
selection against expression of MLKL in ripk1/ MEF, further
supporting the idea that RIPK1 functions to prevent MLKL-
dependent death. The increased expression of MLKL induced
by IFNs may contribute to necroptosis, but this alone cannot
account for the death observed in ripk1/ MEF, as the levels
in these cells did not exceed those seen inWTMEF (Figure S6A),
and the effects were dependent on RIPK3 (Figures 7B, S5A,
and S5B).
Although engagement of RIPK3 (andMLKL) promotes necrop-
tosis, which may contribute to the perinatal death of ripk1/
mice, the RIPK3-MLKL interaction also promotes inflammatoryFigure 6. In the Absence of RIPK1, RIPK3-MLKL-Dependent Cell Deat
(A) Model for the activation of RIPK3 via a RIPK1-independent mechanism. In WT
that is inhibited by RIPK1 through the recruitment of the suppressive FADD-casp
MLKL-mediated necroptosis.
(B) Survival of pups from intercrosses of ripk1+/trif/, ripk1+/tnfr1/, or ripk
ripk1/tnfr1/ (p = 0.008) and ripk1/trif/ (p < 0.0001). Ripk1/tnfr1/ sur
(C) 3T3-SA cells stably expressing 2vFV-TRIF-HA were transfected with either scr
or presence of zVAD (25 mM). Cell death was assessed by Sytox Green uptake
independent experiments. Error bars represent SD.
(D) 3T3-SA expressing 2Fv-TRIF-HA were subjected to immunoprecipitation (IP) o
treatment with AP-1 (10 nM) in the absence or presence of zVAD (50 mM).
(E) Mlkl/ MEF expressing DOX-inducible tagged MLKL (N-term FLAG-MLKL, l
RIPK1 siRNAs and then treated with DOX (1 mg/ml), poly I:C (50 mg/ml), zVAD (50
uptake using an Incucyte Kinetic Live Cell Imager. Data are representative of two
(F) Cell death of cells treated in (E) by propidium iodide uptake using flow cytom
ments. Error bars represent SD.
(G) In the same experiment as (E) and (F), MLKL was immunoprecipitated with a
MLKL via FLAG (N-Term, left, C-Term, right) of mlkl/ MEF treated as indicated
(H) IP of endogenous RIPK1 in mlkl/ MEF expressing FLAG-MLKL (N-Term) t
blotting with the indicated antibodies.
See also Figure S4.cytokine production (Kang et al., 2013). We therefore compared
the in vivo cytokine levels in mice injected with lipopolysaccha-
ride (LPS) (Figure S7). In comparison to WT, ripk3/ mice, or
ripk3/casp8/ mice, animals lacking ripk1, ripk3, and casp8
showed reduced cytokine levels. Therefore, it is likely that
RIPK1 promotes cytokine production in response to LPS, as
observed by others (Lukens et al., 2013), though this did not
appear to depend on the presence of RIPK3 or caspase-8
(except in the case of IL-1b, as described [Gurung et al.,
2014]). Therefore, it is unlikely that a lack of RIPK1, per se,
directly promotes RIPK3-MLKL-dependent inflammation, at
least via TLR engagement. Rather, in work accompanying this
paper in this issue of Cell, RIPK1 appears to inhibit inflammation,
as systematic inflammation is found in postnatal ripk1/
mice, an effect that is dampened in ripk1/ripk3/ and
ripk1/mlkl/ mice (Rickard et al., 2014). It is possible, how-
ever, that a failure to upregulate key cytokines in response to
establishment of the microbiota around birth may contribute to
postnatal lethality in ripk1/ mice. Although no evidence of
bacterial sepsis has been found in these animals (Cusson
et al., 2002; Kelliher et al., 1998), we cannot formally rule out
this possibility.
DISCUSSION
The elucidation of the function of a gene from mutant pheno-
types and the effects of other mutations on those phenotypes
is often confounded by the complexities of the genetic inter-
actions. Our finding that the perinatal lethality of ripk1/ mice
can be prevented with combinations of additional mutations per-
mits two broad conclusions that are, on the surface, fairly
straightforward: (1) RIPK1 functions to prevent perinatal lethality
caused by the activity of TNFR1, FADD, and caspase-8 and (2)
RIPK1 functions to prevent perinatal lethality caused by the
activity of TRIF, IFN, and RIPK3. Thus, these proteins operate
in two different cell death pathways (the death receptor pathway
of apoptosis and RIPK1-independent necroptosis), andwhile the
genetic evidence alone does not permit us to formally concludeh Is Potentiated in Response to Poly I:C
cells (left), a signal (signal 2) is capable of directly activating RIPK3, a process
ase-8-FLIP complex. In the absence of RIPK1 (right), RIPK3 activation leads to
1+/tnfr1/trif/ animals. Ripk1/tnfr1/trif/ survival was compared to
vival was compared to ripk1/trif/ (p < 0.0001).
ambled or RIPK1 siRNA and treated with AP-1 dimerizer (10 nM) in the absence
using an Incucyte Kinetic Live Cell Imager. Data are representative of three
f HA following the transfection of either scrambled or RIPK1 siRNAs and 45min
eft, and C-Term MLKL-FLAG, right) were transfected with either scrambled or
mM), and/or Nec1 (30 mM) as indicated. Cell death assessed by Sytox Green
independent experiments. Error bars represent SD.
etry 10 hr after treatment. Data are representative of two independent experi-
nti-FLAG and coimmunoprecipitated proteins assessed by western blot. IP of
for 4 hr.
reated as in (E). For all cases, immune complexes were detected by western
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Figure 7. In the Absence of RIPK1, RIPK3-
Dependent Cell Death Is Potentiated in
Response to Interferons
(A) Survival of pups from intercrosses of ripk1+/
ifnar/, ripk1+/tnfr1/, or ripk1+/tnfr1/
ifnar/ animals. Ripk1/tnfr1/ifnar/ survival
was compared to ripk1/tnfr1/ (p = 0.0001) and
ripk1/ifnar/ (p < 0.0001). Ripk1/tnfr1/
survival was compared to ripk1/ifnar/ (p =
0.0079).
(B) Cell death assessed by propidium iodide up-
take via flow cytometry of primary MEF of the
specified genotypes treated in the presence or
absence of Interferon-g (IFNg) (100 ng/ml) or
interferon-b (IFNb) (1000 U/ml). Data are repre-
sentative of three independent experiments. Error
bars represent SD.
(C and D) Cell death assessed by propidium iodide
uptake via flow cytometry of primary ripk1+/+ or
ripk1/ MEF treated in the presence or absence
of (C) IFNg (100 ng/ml), zVAD (25 mM), and/or Nec1
(30 mM) or (D) IFNb (1000 U/ml), zVAD (25 mM),
and/or Nec1 (30 mM) as indicated. Data are
representative of three independent experiments.
Error bars represent SD.
(E) Cell death assessed by propidium iodide up-
take via flow cytometry of primary mlkl+/+ or
mlkl/MEF treated in the presence or absence of
IFNg (100 ng/ml), IFNb (1000 U/ml), TNF (10 ng/
ml), and/or zVAD (25 mM) as indicated. Data are
representative of two independent experiments.
Error bars represent SD.
(F) Model of RIPK1 function in cell death. (Left) In
WT cells, both signal 1 (TNF) and signal 2 (TLR/
TRIF or interferons) induce cell death pathways
that are held in check via RIPK1. TNF treatment
activates RIPK1, leading to the formation of active
RIPK3-MLKL complexes while also recruiting and
activating caspase-8 via FADD. RIPK1-mediated
FLIP expression inhibits caspase-8-dependent
apoptosis and leads to the formation of a hetero-
dimer with caspase-8, which inhibits activated
RIPK3. Signal 2 (TLR/TRIF or interferons) can
directly induce the formation of active RIPK3-
MLKL complexes. However, RIPK1 is also
recruited, bringing FADD-caspase-8-FLIP that
terminates the necrotic signal. Inhibition of RIPK3-
MLKL activation can be achieved via Nec1 treat-
ment, whereas zVAD treatment potentiates
RIPK3-mediated necroptosis by inhibiting the
FADD-caspase-8-FLIP complex. (Right) In the
absence of RIPK1, FLIP is downregulated, and
the ligation of TNFR1 leads to the formation of
caspase-8 homodimers and apoptosis. Also, in
the absence of RIPK1, FADD-caspase-8-FLIP
cannot be recruited to the RIPK3-MLKL com-
plexes initiated by TLR/TRIF or IFNs, resulting in
necroptosis.
See also Figures S5, S6, and S7.that RIPK1 is required only to prevent both pathways of cell
death engaged following birth, the results are highly suggestive
of this conclusion.
The prevention of perinatal lethality in the ripk1/ mouse by
ablation of these two cell death pathways was not fully antici-
pated based on previous studies in vitro or in vivo. Although pri-1198 Cell 157, 1189–1202, May 22, 2014 ª2014 Elsevier Inc.mary MEF from ripk1/ mice display increased sensitivity to
TNF-induced apoptosis (Kelliher et al., 1998), RIPK1 has also
been shown to promote FADD-dependent caspase-8 activation
in response to TNF (Feoktistova et al., 2011; Oberst et al., 2011;
Tenev et al., 2011; Zhang et al., 2011) and other stimuli
(Kreuz et al., 2004; Lin et al., 2000; Ma et al., 2005). Similarly,
RIPK3-dependent necroptosis induced by TNF (Degterev et al.,
2005), TLR-ligands (He et al., 2011), or interferons (Thapa et al.,
2013) is effectively blocked by the RIPK1 inhibitor, Nec1, sug-
gesting that RIPK1 functions via its kinase activity to promote
RIPK3 activation and necroptosis, an idea supported by struc-
tural studies of RIPK1-RIPK3 interactions (Li et al., 2012). Our
results extend the latter conclusion and suggest that, under con-
ditions in which RIPK3 is activated independently of RIPK1
(TRIF, IFNs), RIPK1 inhibits necroptosis by recruiting zVAD-
inhibitable caspase activity, likely by the action of FADD-cas-
pase-8-FLIP (Green et al., 2011). In the absence of caspase ac-
tivity, Nec1 inhibits necroptosis in a RIPK1-dependent manner,
suggesting that the Nec1-bound RIPK1 disrupts RIPK3 function.
Indeed, we found that Nec1 inhibits the association of RIPK3 and
MLKL induced by the TLR3 ligand, poly I:C, but only in the pres-
ence of RIPK1 (Figures 6G and 6H).
Our in vitro and in vivo evidence show that loss of RIPK1
sensitizes primary cells to both TNFR1-FADD-caspase-8-medi-
ated apoptosis induced by TNF and RIPK3-mediated necro-
ptosis induced by TLR ligation (via TRIF) or interferons. We
have previously shown that enforced oligomerization of RIPK3
is sufficient to induce MLKL-dependent necroptosis (Tait et al.,
2013). Therefore, oligomerization of TRIF and thus RIPK3 can
promote the activation of the latter independently of RIPK1.
When RIPK1 is present, recruited caspase activity prevents
this activation and interaction with MLKL. These results are
consistent with models of RIPK1 and RIPK3 interaction (Li
et al., 2012). In the case of interferon exposure, we propose
that PKR contributes to RIPK1-independent activation of
RIPK3, as suggested by others (Thapa et al., 2013), although
the precise mechanisms remain obscure.
In mice lacking both ripk1 and ripk3, perinatal lethality is fully
penetrant, although our data show that this is dependent on
TNFR1, FADD, and caspase-8. Our models suggest that
apoptosis, engaged by the latter, is responsible for this lethality.
Indeed, we observed widespread apoptosis in these animals.
Although apoptosis is readily detected by histological methods,
it is more difficult to detect necroptosis, and therefore we can
only speculate at this point that perinatal lethality in ripk1/
mice is due to a mixture of apoptotic and necrotic death in the
same tissues undergoing apoptosis in the ripk1/ripk3/
mice. Further, because RIPK3-MLKL interactions can produce
inflammatory effects, apparently independently of cell death
(Kang et al., 2013), we cannot exclude that such inflammation,
rather than cell death, contributes to perinatal lethality in the
ripk1/ mice, although widespread inflammation was not
observed in these animals when originally reported (Kelliher
et al., 1998). Such an effect, however, would be excluded in
the case of ripk1/ripk3/ mice. In the latter, we and Rickard
et al. observed some delay in perinatal lethality versus ripk1/
mice, supporting this idea (Rickard et al., 2014).
Our data support a model of RIPK1 function in development
and postnatal life (Figure 7F). Because ablation of RIPK1 sensi-
tizes for both TNFR1-FADD-caspase-8-dependent and RIPK3-
dependent lethality, we must assume that these pathways are
not engaged prior to birth. FADD- or caspase-8-deficient mice
die in utero, and this embryonic lethality is fully prevented upon
ablation of RIPK3 (Dillon et al., 2012; Kaiser et al., 2011; Oberstet al., 2011). However, because RIPK1-deficient animals survive
to birth, the signals responsible for such embryonic lethality are
not held in check by RIPK1 and, indeed, are promoted by it. Prior
to birth, RIPK1 promotes TNFR-mediated lethality at E10.5 in
animals lacking fadd, caspase-8, or flip (Zhang et al., 2011 and
Figure 5) and lethality at a later developmental checkpoint that
might be mediated by similar signals, perhaps from other
TNFR-related receptors (or another signal with the properties
of signal 1). We observed that cells lacking RIPK1 do not
undergo necroptosis in response to TNFR ligation, consistent
with other observations (Vandenabeele et al., 2010), supporting
the idea that the later-stage lethality seen in casp8/tnfr1/
embryos is mediated by a TNFR1-like necroptosis-inducing
signal. At the time of birth, RIPK1 is required to prevent a
TNFR1-induced FADD- and caspase-8-dependent lethality in
ripk1/ripk3/ animals, possibly relating to a failure to upregu-
late FLIP in response to TNFR1 signaling. If so, FLIP, which is
required for development beyond E10.5, must be expressed at
that time independently of RIPK1.
Postbirth, RIPK1 is also required to prevent RIPK3-dependent
lethality promoted by TRIF, IFN, and possibly other signals. It is
likely that this inhibition is mediated by the recruitment, via
RIPK1, of FADD-caspase-8-FLIP, which does not promote
apoptosis but which functions catalytically to inhibit RIPK3 func-
tion (Green et al., 2011), directly engaged by these signals.
Mice with a kinase-dead mutation of RIPK1 show normal
development and maturation, although cells from these animals
appear to be defective in TNF-induced necroptosis (Newton
et al., 2014). The mechanisms by which the kinase activity of
RIPK1 either promotes or prevents cell death in other contexts
still remain obscure. Strikingly, mice with a kinase-dead
mutation of RIPK3 die at E10.5 and were rescued to birth by
ablation of RIPK1 or fully rescued by ablation of caspase-8
(Newton et al., 2014), indicating that RIPK3 can itself engage
both RIPK1 and caspase-8. Although it remains unclear why
kinase-dead RIPK3 is hyperactive in this regard, the results are
consistent with the pathways described; disruption of either
the necroptotic pathway (by mutation of the RIPK3 kinase
domain) or the apoptotic pathway (by ablation of caspase-8,
FADD, or FLIP) ‘‘unbalances’’ the system in favor of lethality by
the other pathway. Ablation of RIPK1 similarly unbalances these
pathways but only after birth, suggesting that the inhibitory func-
tion of RIPK1 only becomes essential when additional signals
(such as TLR/TRIF and IFN) manifest.
RIPK1 is under complex regulation by a number of ubiquitin
ligases and deubiquitinases. cIAP1/2 mediate K63 ubiquiti-
nylation of RIPK1, whereas LUBAC (HOIP, HOIL, sharpin)
causes linear ubiquitylation of RIPK1, both of which are
involved in recruitment of NEMO (Bertrand et al., 2008; Gerlach
et al., 2011) The deubiquitinase CYLD removes the K63-Ub,
promoting activity in necroptosis (Moquin et al., 2013). In
contrast, A20 ‘‘edits’’ these linkages from K63 to K48 (Wertz
et al., 2004), destabilizing the protein. How these interactions
may impact the complex patterns that we observed for the
maintenance of perinatal life remain obscure. However, one
might expect that intracellular pathogens that disrupt elements
of this process at any of a variety of points would trigger cell
death, preventing further spread of the pathogen. If so, thisCell 157, 1189–1202, May 22, 2014 ª2014 Elsevier Inc. 1199
may suggest a reason why this complex interrelationship exists
and why ablation of specific elements (including RIPK1, FADD,
caspase-8, FLIP, and the kinase activity of RIPK3) push the
system to lethality. It may also be relevant that the tissues
that are most affected by such disruption (intestine, lung,
skin, endothelium, hematopoietic cells) (Khan et al., 2014)
represent barriers that are potentially engaged by such
pathogens.
EXPERIMENTAL PROCEDURES
For further experimental procedures, please see the Extended Experimental
Procedures.
Mice, In Vivo Treatments, and Serum Analysis
Ripk3/casp8/ (Oberst et al., 2011), ripk3/fadd/ (Dillon et al., 2012),
ripk1/ (Kelliher et al., 1998), tnfr1/ (Pfeffer et al., 1993), cflar/ (Yeh
et al., 2000), trif/(Yamamoto et al., 2003), and ifnar/ (Mu¨ller et al., 1994)
mice have been previously described. Themlkl/mice were generously pro-
vided prior to publication byWarren S. Alexander (Murphy et al., 2013). The St.
Jude Institutional Animal Care and Use Committee approved all procedures in
accordance with the Guide for the Care and Use of Animals.
Cell Lines
Primary murine embryonic fibroblasts (MEF) were generated by mating
animals of the required genotypes and harvesting embryos at E12–E14 based
on palpation. Following removal of the head and fetal liver, a single suspension
was generated from the remaining parts of the embryo and plated in DMEM
supplemented with 10% FCS, L-glutamine, pen/strep, 55 mM b-mercaptoe-
thanol, 1 mM sodium pyruvate, and nonessential amino acids (GIBCO). All
experiments on primary MEF were performed on cells no older than passage
3, and data shown represent experiments using independently derived MEF.
Some of the primary MEF were immortalized with SV40 and maintained in
DMEM as above except with 5% FCS.
Immune Cell Staining, Cell Death, and Activation Assays
For immune cell staining, the spleen, thymus, and lymph node were harvested
from animals and disassociated into single-cell suspensions through a filter.
For immune cell staining from the blood, blood was harvested from the retro-
orbital sinus from animals anesthetized with 2%–2.5% isoflurane in oxygen.
Red blood cells were lysed in hypotonic buffer, and samples were stained
with antibodies as described below. Data were acquired using a FACScan
or Fortessa using FlowJo Collectors or FACSDiva software, respectively,
whereas data analysis was performed using FlowJo (Tree Star). For cell death
assays, cells were treated with the specified compounds and harvested at the
indicated time points, stained with propidium iodide (Sigma-Aldrich), and
assayed for viability using flow cytometry. In some cell death assays, cells
were stained with Annexin V-APC (Invitrogen) in addition to propidium iodide.
For cleaved caspase-3 intracellular staining, cells were harvested at the indi-
cated time points, fixed, permeabilized, and stained per manufacturer’s
instructions (BD Biosciences). Alternatively, cell death analysis was performed
using an Incucyte Kinetic Live Cell Imaging system by staining cells with Sytox
Green (Life Technologies) and then imaging every 30 min to 1 hr for the length
of the experiment. Proliferation assays and culture conditions for T cells were
performed per standard protocols as follows: splenic T cells were isolated
fromwhole spleen usingmagnetic separation (Pan T cell isolation kit II, Miltenyi
Biotec [130-095-130]). Cells were stained with CFSE and plated at 1 3 105
cells per well in 96-well plates with plate-bound anti-CD3 (4 mg/ml) and anti-
CD28 (4 mg/ml). Splenocytes were cultured in RPMI 1640 (Invitrogen) supple-
mented with 10% FCS, L-glutamine, pen/strep, 55 mM b-mercaptoethanol,
1 mM sodium pyruvate, and nonessential amino acids (GIBCO).
Immunoprecipitation of MLKL and TRIF
N- and C-terminal FlagM2-tagged mMLKL were cloned into the doxycycline-
inducible vector pRetroX-TRE3G (631188; Clontech, CA. USA). WT ormlkl/1200 Cell 157, 1189–1202, May 22, 2014 ª2014 Elsevier Inc.MEF were transduced and selected with 4 mg/ml puromycin according to
manufacturer’s instructions. In brief, MLKL expression was induced by incu-
bating mlkl/ MEF with 1 mg/ml DOX for 4 hr for immunoprecipitation and
for 10 hr for cell death experiments. During induction, cells were all incubated
with 50 mg/ml poly I:C or 10 ng/ml TNF in the presence or absence of 50 mM
zVAD and/or 30 mM Nec1. For immunoprecipitation experiments with N-term
FLAG-MLKL pull-downs in WT MEF, MLKL expression was induced for
24 hr before treatment with 1 mg/ml DOX. 3T3-SA cells transduced with
pMSCV-2Fv-mTRIF-HA-IRES-mCherry were selected by cell sorting. TRIF
dimerization was induced using 10 nM AP-20187 homodimerizer in the
absence or presence of 25 mM zVAD. Cell lysates were generated using a lysis
buffer containing: 50 mM Tris (pH 7.4), 150 mM NaCl, 1 mM EDTA, 0.5%
NP-40, and Cocktail Protease Inhibitor (Roche). FLAG immunoprecipitation
was performed using anti-FLAG beads according manufacturer instructions
(Sigma, F2426). Endogenous immunoprecipitation for RIPK1 was performed
by coupling anti-RIPK1 (610458; BD PharMingen) with protein A/G PLUS-
Agarose (sc-2003; Santa Cruz Biotechnologies). HA immunoprecipitation
was performed using anti-HA beads (A2095; Sigma). All eluted immunoprecip-
itates were boiled, and 5% of input was loaded onto 4%–12% precast gels
(Bio-Rad). After transfer, membranes were probed with the specified
antibodies.
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